SRA's number for the day: 4
This article was originally published in SRA
Executive Summary
The European Medicines Agency is being reorganized and will soon have four new divisions focussing on: supporting the R&D phase in drug companies; medicines evaluation and lifecycle management; procedure management and business data; and inspections and pharmacovigilance1.